"cell lung" trang 7 - tải miễn phí từ tailieunhanh
The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre

The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre
8    61    1
The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis
17    41    1
Survival-associated N6 -adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification

Survival-associated N6 -adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification
14    53    1
MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-smallcell lung cancer

MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-smallcell lung cancer
16    44    1
Evaluating the treatment results of vinorelbine monotherapy in non-small cell lung cancer

Evaluating the treatment results of vinorelbine monotherapy in non-small cell lung cancer
7    56    1
Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings

Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
11    13    1
Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer

Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer
23    11    1
Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases

Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases
6    11    1
Analysis of EGFR gene mutation in patients with non-small cell lung cancer in Hue Central Hospital

Analysis of EGFR gene mutation in patients with non-small cell lung cancer in Hue Central Hospital
5    1    1
Intestinal T-cell lymphoma with lung and lymph node involvement at relapse

Intestinal T-cell lymphoma with lung and lymph node involvement at relapse
6    2    1
Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)

Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)
11    1    1
MALAT1-regulated gene expression profiling in lung cancer cell lines

MALAT1-regulated gene expression profiling in lung cancer cell lines
14    1    1
Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: A retrospective study

Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: A retrospective study
15    1    1
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
6    1    1
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
11    5    1
Dissection of paracrine/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis

Dissection of paracrine/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis
18    5    1
Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease

Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease
6    7    1
A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol

A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol
6    1    1
Long-term results of postoperative unsuspected small cell lung cancer on real-world data

Long-term results of postoperative unsuspected small cell lung cancer on real-world data
10    2    1
Immune characteristics analysis and construction of a four-gene prognostic signature for lung adenocarcinoma based on estrogen reactivity

Immune characteristics analysis and construction of a four-gene prognostic signature for lung adenocarcinoma based on estrogen reactivity
16    2    1